This site is intended for healthcare professionals only
LoginRegister
Eli Lilly joins trillion-dollar club, fueled by weight loss drug demand boomUSFDA greenlights label update for Eli Lilly Amyvid to support Alzheimer's disease diagnosis in...
Sanofi Gets CDSCO Panel Nod to Update Prescribing Information for XenpozymeUSFDA grants orphan drug designation to Sanofi Riliprubart for AMR in solid organ transplantation
USV Acquires 79% Stake in Wellbeing Nutrition, Values D2C Startup at Rs 1,583 CrNovartis concludes acquisition of Regulus Therapeutics
AstraZeneca Saphnelo subcutaneous self-administration recommended for approval in EU by CHMP for systemic lupus erythematosusAstraZeneca-Daiichi Sankyo Datroway gets USFDA accelerated nod for previously treated advanced...
Eli lilly, Circle Pharma ink pact to further enhance AI/ML capabilitiesGilead Sciences, Kymera Therapeutics ink pact to develop novel oral molecular glue CDK2 degraders
Around 5,000 Small Pharma Units at Risk as Centre Enforces Tougher GMP NormsSMS Pharma successfully completes USFDA inspection at Telangana Central Laboratory Analytical...
India imposes anti-dumping duty on six Chinese productsIndia tightens grip on Chinese imports with anti dumping duty on six products
Prior Intimation System Under NDCT Rules Wont Apply to Hormones, Cytotoxics, Beta-Lactams, Certain Biologics: CDSCO58 Unauthorised Clinical Trials Spark DCGI Ban on VS Hospital, Doctors, Pharma Giants Under Fire
CDSCO Clears AstraZenecas Imfinzi (Durvalumab) for Additional Cancer Indication in IndiaLabel Update for AstraZeneca's Olaparib Cleared by CDSCO Panel
Biocon Biologics Secures BB+ Rating Upgrade from S&P on Improved Financial MetricsBiocon Gets CDSCO Panel Nod to Market Trastuzumab PGS in India
USFDA Flags Compliance Issues at Novo Nordisks New Jersey FacilityWeight loss drug: Novo Nordisk Wegovy now available in India
R21 Vaccine Not for India Yet, Government Informs ParliamentBharat Biotech to cut malaria vaccine RTS.S price to under USD 5 for children in endemic countries
X